Casey McAllister has been appointed as the new vice president of finance at the National Community Pharmacists Association (NCPA). Read More »

The article discusses Anthony DiGiorgio's insights on how the federal 340B Drug Pricing Program incentivizes hospital consolidation by favoring high-priced drugs over independent oncologists. Read More »

A pharmacy recently reported an incident in which a patient received a mixture of two controlled substances due to an error involving return-to-stock (RTS) medication vials. Read More »

The Centers for Disease Control and Prevention (CDC) has updated its guidance on COVID-19 vaccination, moving to an “individual-based decision-making” model. Read More »

In an episode aired in October 2025, ABC News' Nightline explored the risks linked to fake glucagon-like peptide-1 (GLP-1) medications being sold on the internet. Read More »

The SUPPORT for Patients and Communities Reauthorization Act of 2025 has been signed into law. Read More »

The article discusses concerns raised about pharmacy benefit managers' (PBMs) impact on drug costs due to opaque pricing strategies. Read More »

The National Community Pharmacists Association (NCPA) responded to President Trump’s recently announced “Great Health Care Plan,” highlighting both positive aspects and areas needing further attention. Read More »

NABP has provided information on how businesses can get ready for inspections or accreditation surveys. Read More »

The Food and Drug Administration (FDA) has announced a proposal to simplify the research process for biosimilar products. Read More »

The Food and Drug Administration (FDA) has announced it will require changes to the prescribing labels for tranexamic acid injections. Read More »

United States Pharmacopeia (USP) has released new resources aimed at helping pharmaceutical manufacturers ensure the quality of glucagon-like peptide-1 (GLP-1) agonists. Read More »

In 2024, an estimated 1.4 billion people worldwide had hypertension, but only around 20% were able to control the condition through medication or lifestyle changes, according to a recent report by the World Health Organization (WHO). Read More »

The National Community Pharmacists Association (NCPA) has expressed support for a new provision in a congressional spending bill that would require the Centers for Medicare & Medicaid Services to establish clearer contract terms under Medicare... Read More »

Ross Marchand, Executive Director of the Taxpayers Protection Alliance (TPA), said on the Health Policy Podcast that the 340B drug discount program is enriching hospitals and insurers while failing the poor it was designed to help. Read More »

Pharmacist and pharmacy organizations have expressed strong support for H.R. 7148, the Consolidated Appropriations Act of 2026, which includes provisions aimed at reforming pharmacy benefit managers (PBMs). Read More »

The article discusses concerns regarding hospital profits from discounted cancer drugs under the federal 340B program. Read More »

PCCA and Eagle have recognized outstanding employees in their North American operations during recent annual celebrations. Read More »

The National Community Pharmacists Association (NCPA) has responded to the U.S. House of Representatives’ recent passage of a spending bill that contains provisions aimed at reforming pharmacy benefit manager (PBM) practices within Medicare Part... Read More »

The rapid expansion of the 340B Drug Pricing Program has sparked concerns over its effectiveness in improving access or reducing costs. Read More »